NEOUSD is on very healthy bullish technicals on the 1D timeframe (RSI = 67.236, MACD = 1.232, ADX = 36.412) and just crossed over the 1W MA200 for the first time since April 4th 2022. The blueprint of this Cycle is the same as the previous. The token bottoms on a Triangle shaped double bottom and then starts rising on a Channel Up before it breaks upwards aggressively for the Cycle's final rally.
It seems that now we are entering a short term consolidation phase which will give way to the final rally. We are expecting a direct hit on the LH trendline (TP = 100.00).
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
It seems that now we are entering a short term consolidation phase which will give way to the final rally. We are expecting a direct hit on the LH trendline (TP = 100.00).
## If you like our free content follow our profile to get more daily ideas. ##
## Comments and likes are greatly appreciated. ##
Telegram👉 t.me/investingscope , investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% profit monthly on Account Management Plan.
Subscribe to our wealth making YouTube Channel👉youtube.com/@InvestingFlix
Over 65% accuracy on Private Signals Channel.
Over 15% profit monthly on Account Management Plan.
Subscribe to our wealth making YouTube Channel👉youtube.com/@InvestingFlix
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Telegram👉 t.me/investingscope , investingscope.com
Over 65% accuracy on Private Signals Channel.
Over 15% profit monthly on Account Management Plan.
Subscribe to our wealth making YouTube Channel👉youtube.com/@InvestingFlix
Over 65% accuracy on Private Signals Channel.
Over 15% profit monthly on Account Management Plan.
Subscribe to our wealth making YouTube Channel👉youtube.com/@InvestingFlix
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.